0001655145-15-000001.txt : 20151014 0001655145-15-000001.hdr.sgml : 20151014 20151014123210 ACCESSION NUMBER: 0001655145-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151014 DATE AS OF CHANGE: 20151014 EFFECTIVENESS DATE: 20151014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Concentrx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001655145 IRS NUMBER: 270908176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-249336 FILM NUMBER: 151157776 BUSINESS ADDRESS: STREET 1: 749 9TH STREET STREET 2: SUITE 301 CITY: DURHAM STATE: NC ZIP: 27705 BUSINESS PHONE: 919-306-1409 MAIL ADDRESS: STREET 1: 749 9TH STREET STREET 2: SUITE 301 CITY: DURHAM STATE: NC ZIP: 27705 D 1 primary_doc.xml X0707 D LIVE 0001655145 Concentrx Pharmaceuticals, Inc. 749 9TH STREET SUITE 301 DURHAM NC NORTH CAROLINA 27705 919-306-1409 DELAWARE None None Corporation true 2014 Gilbert S. Mott 749 9th Street Suite 301 Durham NC NORTH CAROLINA 27705 Executive Officer Director Eric C. Richardson 749 9th Street Suite 301 Durham NC NORTH CAROLINA 27705 Executive Officer Director Biotechnology Decline to Disclose 06b false 2015-09-30 false true true false 0 1000000 307876 692124 false 11 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Concentrx Pharmaceuticals, Inc. /s/ Gilbert S. Mott Gilbert S. Mott, Jr. President 2015-10-14